
Designing containers that prevent a decrease in the concentration of Drug Adsorption – Zelas™CP, a low-adsorption container material that enhances product formulation flexibility.
In recent years, the beauty and healthcare sector has seen a growing trend of consumers choosing products based on their ingredients rather than brand image or recognition—a phenomenon known as "ingredient-based purchasing." Maintaining the quality of active ingredients has become a crucial factor influencing product value. However, often overlooked are packaging-related issues such as ingredient adsorption and degradation due to container materials. Addressing these challenges, which cannot be fully resolved through formulation design alone, from the container side is key to successful development. This article will discuss the mechanisms of active ingredient degradation, countermeasures, and introduce resin materials that are attracting attention as a new solution.
Table of Contents [hide]
- 1.Do you have any of these problems?
- 2.Causes and countermeasures for the decrease in active ingredient concentration
- 2.1Causes of decrease in active ingredient concentration
- 2.2.Components and mechanisms that are easily adsorbed onto container materials
- 2.3.Countermeasures – Prescription or container?
- 3.Features of Zelas™CP (container material)
- 3.1.Adsorption Inhibition Evaluation
- 3.2.Lowspecific gravity, low moisture permeability
- 3.3.Fusibility with polyolefins
- 3.4.Excellent heat sealability
- 3.5.Achieves a premium appearance with high transparency grade.
- 3.6.Medical-grade safety
- 4.Examples of applications where Zelas™CP can be used
- 5.For those who are interested
Do you have any of these problems?
In the development of various pharmaceuticals, toiletries, and cosmetics, it is not uncommon to encounter problems such as a decrease in active ingredients during storage, resulting in products failing to meet approval standards in stability tests.
In particular, with regard to pharmaceuticals, the Ministry of Health, Labour and Welfare's Pharmaceutical Affairs Bureau's Notification No. 568 specifies the content standards for formulations, and cases where the content of the active ingredient does not fall within these standards become problematic. 1)
It is essential to understand the mechanism of ingredient reduction and take appropriate measures during the formulation design and container selection stages.
Causes and countermeasures for the decrease in active ingredient concentration
Causes of decrease in active ingredient concentration
- Chemical modification: Decomposition of components through oxidation, hydrolysis, photodegradation, etc.
- Adsorption to container material: Oily or surfactant components migrate to the resin material, reducing their concentration.
- Interactions with other components: Chelate formation by metal ions and surfactants, and promotion of oxidation.
Adsorption originating from the container, in particular, is often overlooked during formulation development, but frequently becomes apparent during stability testing, making it a difficult issue to address in subsequent processes.
Components and mechanisms that are easily adsorbed onto container materials
Adsorption to container materials is mainly a problem with highly lipid-soluble oily components. 2)
These substances are adsorbed by hydrophobic interactions with polyethylene (PE) and polypropylene (PP), which are the main components of the container material, and then diffuse and penetrate into the resin.
Solution – prescription or container?
There are mainly two approaches to addressing the decrease in active ingredient concentration.
Formulation innovations: Stabilization through the inclusion of antioxidants, optimization of surfactant amounts, and pH buffering.
Improved container materials: A resin that suppresses component adsorption is used in the innermost layer.
The latter, in particular, namely reviewing the container material, is effective in increasing formulation flexibility (differentiation from competitors) and shortening the development process, as it improves stability without changing the formulation.
Features of Zelas™CP (container material)
To address these challenges, our company developed Zelas™CP, a next-generation resin that balances heat-sealability, adhesion to other materials, appearance, and hygiene while suppressing the adsorption of active ingredients.
Adsorption suppression evaluation
As an example of an oily component, tocopherol acetate (vitamin E) was used as the active ingredient to evaluate its adsorption behavior. The results showed that Zelas™CP exhibited a higher active ingredient retention rate compared to PE.
Zelas™CPsuppresses adsorption by combining multiple resins with structures that make it difficult for active ingredients to penetrate.
Low specific gravity, low moisture permeability
Zelas™CP boasts a low specific gravity and low moisture permeability comparable to polyolefins (PE and PP). Compared to PET and PS (polystyrene), it is lighter and reduces the risk of product content deterioration and evaporation during storage, enabling both lighter containers and improved content stability.
Fusion with polyolefins
Zelas™CP exhibits high fusion properties with polyolefins (PE and PP), enabling container design using multi-layer blow molding and multi-layer co-extrusion. By placing Zelas™CP as the wetted layer (innermost layer) and using existing polyolefins (PE or PP) for the outer layer to adjust mechanical strength and appearance, design flexibility is ensured, making it easy to introduce into existing lines and a cost-effective improvement method.
Excellent heat sealability
The film-grade XLCP201 (under development) exhibits excellent heat-sealing properties with other Zelas™CP materials, making it possible to develop various forms such as pouch packaging and laminated tubes, which were difficult to achieve with PET.
Achieves a premium appearance with a highly transparent grade.
Blow-molded CP208 offers exceptionally high transparency, creating a glass-like appearance. It combines the functionality of transparent packaging with the ability to protect active ingredients.
Medical-grade for peace of mind
Zelas™CP originally has a proven track record as a material for pharmaceutical packaging containers. We will bring the reliable technology of high hygiene and low drug adsorption cultivated in the medical field to the cosmetics field as well.
Examples of applications where Zelas™CP can be used
- Cosmetics and Personal Care
Various containers, (refill) pouches, and tubes for lotions, emulsions, serums, face masks, sunscreens, hair styling products, shampoos and conditioners, body soaps, professional salon products, and doctor-developed cosmetics. - Toiletries and household goods
Bottles, refill pouches, and sachets for hand soap, body lotion, mouthwash, cleaning and disinfecting agents, detergents, fabric softeners, etc. - Quasi-drugs, over-the-counter (OTC) medicines, pharmaceuticals
Bottles, pouches, and laminated tubes for topical solutions, ointments/creams, eye drops, mouthwashes, oral care preparations, and quasi-drugs for skin care. - Other functional liquids and industrial applications
Containers for insect repellent products, functional fragrances, and industrial liquids where the stability of specific ingredients is crucial (bottles, multi-layer containers, tubes, primary packaging materials, etc.).
For those who are interested
If you're facing challenges such as "preventing the reduction of active ingredients," "finding a container that can pass stability tests without changing the formula," or "solving adsorption problems with existing PE containers," then please consider evaluating Zelas™CP.
We also provide detailed technical data, adsorption evaluation results, and support for multilayer container design.
Please feel free to contact us using the form below.
References
1) Director, Pharmaceutical Affairs Bureau, Ministry of Health, Labour and Welfare. "Regarding the Establishment of Standards and Test Methods for New Pharmaceuticals," Pharmaceutical Affairs Bureau Notification No. 568, May 1, 2001. PMDA (Pharmaceuticals and Medical Devices Agency) Public Document.https://www.pmda.go.jp/files/000156301.pdf
2) Japanese Patent Publication No. 10-85304, "Method for preventing and adsorption of fat-soluble vitamins into containers," Published Patent Application, April 7, 1998.



